“…Some high‐performance liquid chromatography (HPLC) methods have been applied for the analysis of CNZ in rat or human plasma (Deepan, Rao, & Dhanaraju, 2017; Dudhe & Kamble, 2016; Iqbal, Khalil, Alanazi, & Al‐Rashood, 2015; Mabrouk, Soliman, El‐Azigy, & Mansour, 2020). Various LC–mass spectrometry (MS)/MS methods have also been reported for the determination and evaluation of pharmacokinetic profile of CNZ in rat or human or rabbit plasma (Bhatt & Rajkamal, 2018; Deepan, Rao, & Dhanaraju, 2019; Dias et al, 2019; Dong et al, 2018; Iqbal, Ezzeldin, et al, 2015; Kobuchi, Yano, Ito, & Sakaeda, 2016; Ramisetti, Atmakuri, Venkatay, & Adireddy, 2019; Saibaba, Pilli, Bimireddy, & Pandiyan, 2018; Shah et al, 2019; Shah & Shrivastav, 2018; Udhayavani, Sastry, Rajan, Tejaswi, & Rajani, 2018). LC–MS/MS‐based quantitative analysis of drugs in biological fluids is the preferred technique owing to its advantages such as sensitivity, selectivity and speed of analysis (Deepan et al, 2019; Iqbal, Ezzeldin, et al, 2015; Shah et al, 2019).…”